Insulin pump therapy in type 1 diabetic patients: Experience at the American University of Beirut Medical Center

International Journal of Diabetes and Metabolism

Volumn 16, Issue 2, 2008, Pages 57-61

  Merheb, M ^a   Chaiban, J ^a   Salti, I ^a   Sammak, R ^a   Choucair, M ^a   Nasrallah, Mona ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Continuous subcutaneous insulin infusion; Insulin pump; Lebanon; Middle East; Type 1 Diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN;

ADOLESCENT; ADULT; APPLICATION SITE INFECTION; ARTICLE; CLINICAL ARTICLE; DRUG DOSE REDUCTION; DRUG EFFICACY; EMOTION; FEMALE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; MALE; PATIENT SATISFACTION; PHYSICAL CAPACITY; QUALITY OF LIFE; SOCIAL STATUS; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 70349566977     PISSN: 16067754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-986.
2. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000; 342: 381-389.
3. Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353:2643-2653.
4. Pickup JC, Keen H, Parsons JA, Alberti KG. Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. Br Med J 1978;1: 204-207.
5. Tamborlane WV, Sherwin RS, Genel M, Felig P. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med 1979; 300: 573-578.
6. Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002; 25: 593-598.
7. Pickup J, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ 2002; 324: 705.
8. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy: a metaanalysis. Diabetes Care 2003;26:1079-1087.
9. Hanaire-Broutin H, Melki V, Bessieres-Lacombe S, Tauber JP. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes. Diabetes Care 2000; 23: 1232-1235.
10. Wainstein J, Metzger M, Wexler ID, et al. The use of continuous insulin delivery systems in severely insulinresistant patients. Diabetes Care 2001; 24: 1299.
11. Wainstein J, Metzger M, Boaz M, et al. Insulin pump therapy vs. multiple daily injections in obese Type 2 diabetic patients. Diabet Med 2005; 22: 1037-1046.
12. Herman WH, Ilag LL, Johnson SL, et al. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care 2005; 28:1568-1573.
13. Ahern JA, Boland EA, Doane R, et al. Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groups. Pediatr Diabetes 2002; 3: 10-15.
14. Maniatis AK, Klingensmith GJ, Slover RH, et al. Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care. Pediatrics 2001; 107: 351-356.
15. Plotnick LP, Clark LM, Brancati FL, Erlinger T. Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care 2003; 26: 1142-1146.
16. Implementation of treatment protocols in the Diabetes Control and Complications Trial. Diabetes Care 1995; 18: 361-376.
17. Springer D, Dziura J, Tamborlane WV, et al. Optimal control of type 1 diabetes mellitus in youth receiving intensive treatment. J Pediatr 2006; 149: 227-232.
18. Rewers A, Chase HP, Mackenzie T, et al. Predictors of acute complications in children with type 1 diabetes. Jama 2002; 287: 2511-2518.
19. Bulsara MK, Holman CD, Davis EA, Jones TW. The impact of a decade of changing treatment on rates of severe hypoglycemia in a population-based cohort of children with type 1 diabetes. Diabetes Care 2004; 27: 2293-2298.
20. Bin-Abbas BS, Sakati NA, Raef H, Al-Ashwal AA. Continuous subcutaneous insulin infusion in type 1 diabetic Saudi children. A comparison with conventional insulin therapy. Saudi Med J 2005; 26: 918-922.
21. Hieronimus S, Cupelli C, Bongain A, et al. [Pregnancy in type 1 diabetes: insulin pump versus intensified conventional therapy]. Gynecol Obstet Fertil 2005; 33: 389-394.
22. Simmons D, Thompson CF, Conroy C, Scott DJ. Use of insulin pumps in pregnancies complicated by type 2 diabetes and gestational diabetes in a multiethnic community. Diabetes Care 2001; 24: 2078-2082.
23. Weintrob N, Benzaquen H, Galatzer A, et al. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial. Pediatrics 2003; 112: 559-564.
24. Wilson DM, Buckingham BA, Kunselman EL, et al. A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. Diabetes Care 2005; 28: 15-19.
25. Doyle EA, Weinzimer SA, Steffen AT, et al. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 2004; 27: 1554-1558.
26. Danne T, Battelino T, Kordonouri O, et al. A crosssectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries. Pediatr Diabetes 2005; 6: 193-198.
27. Litton J, Rice A, Friedman N, et al. Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus. J Pediatr 2002; 141: 490-495.
28. Boland EA, Grey M, Oesterle A, et al. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care 1999; 22:1779-1784.
29. Pickup JC: Long-term use of continuous subcutaneous insulin infusion. Diabetes Res Clin Pract 2006;74 Suppl 2:S101-103.